Terms: = Ovarian cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
94 results:
1. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the treatment of TA-muc1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract] [Full Text] [Related]
2. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
3. Uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
Bai L; Chen Y; Han L; Zheng A; Mo X
BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Data on Olaparib in Relapsed BRCA-mutated ovarian cancer: A Multicenter GINECO RETROLA Cohort Study.
Bourien H; Lefevre LB; Mouret-Reynier MA; Asselain B; Lucas B; Gavoille C; Cornila C; Gavoille L; Colomba E; Patsouris A; Fabbro M; Chakiba C; Toussaint P; Simon H; Berton D; Garbay D; Tixidre CG; Coeffic D; Morvan A; Collard O; DE LA Motte Rouge T
Anticancer Res; 2023 Feb; 43(2):653-662. PubMed ID: 36697069
[TBL] [Abstract] [Full Text] [Related]
5. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
6. Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial ovarian cancer.
Revythis A; Limbu A; Mikropoulos C; Ghose A; Sanchez E; Sheriff M; Boussios S
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886427
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Kahn RM; Ragupathi G; Zhou QC; Iasonos A; Kravetz S; Hensley ML; Konner JA; Makker V; Tew WP; Aghajanian C; Sabbatini PJ; O'Cearbhaill RE
Cancer Immunol Immunother; 2023 Jan; 72(1):183-191. PubMed ID: 35779095
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.].
Danesi R; Cremolini C; Ciccarone F; Lorusso D
Recenti Prog Med; 2021 Jun; 112(6):444-453. PubMed ID: 34128936
[TBL] [Abstract] [Full Text] [Related]
9. Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer.
Le Saux O; Vanacker H; Guermazi F; Carbonnaux M; Roméo C; Larrouquère L; Trédan O; Ray-Coquard I
Future Oncol; 2021 Jun; 17(18):2291-2304. PubMed ID: 33726504
[TBL] [Abstract] [Full Text] [Related]
10. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract] [Full Text] [Related]
11. Trabectedin for the therapy of ovarian cancer.
Evangelisti G; Barra F; D'Alessandro G; Tantari M; Stigliani S; Della Corte L; Bifulco G; Ferrero S
Drugs Today (Barc); 2020 Oct; 56(10):669-688. PubMed ID: 33185631
[TBL] [Abstract] [Full Text] [Related]
12. Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer.
Rimel BJ; Dockery L; Randall LM; Moore K
Future Oncol; 2020 Nov; 16(33):2701-2711. PubMed ID: 32880196
[TBL] [Abstract] [Full Text] [Related]
13. Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.
Adams SF; Grimm AJ; Chiang CL; Mookerjee A; Flies D; Jean S; McCann GA; Michaux J; Pak H; Huber F; Neal C; Dangaj D; Bassani-Sternberg M; Rusakiewicz S; Facciabene A; Coukos G; Gimotty PA; Kandalaft LE
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817208
[TBL] [Abstract] [Full Text] [Related]
14. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract] [Full Text] [Related]
15. 'PARP'ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors.
Rao PD; Sankrityayan H; Srivastava A; Kulkarni YA; Mulay SR; Gaikwad AB
Drug Discov Today; 2020 Jul; 25(7):1253-1261. PubMed ID: 32371137
[TBL] [Abstract] [Full Text] [Related]
16. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
17. ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
18. A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary.
Altal OF; Aleshawi AJ; Tashtush NA; Alhowary A
Am J Case Rep; 2019 Nov; 20():1675-1678. PubMed ID: 31723117
[TBL] [Abstract] [Full Text] [Related]
19. A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
O'Cearbhaill RE; Deng W; Chen LM; Lucci JA; Behbakht K; Spirtos NM; Muller CY; Benigno BB; Powell MA; Berry E; Tewari KS; Hanjani P; Lankes HA; Aghajanian C; Sabbatini PJ
Gynecol Oncol; 2019 Dec; 155(3):393-399. PubMed ID: 31653510
[TBL] [Abstract] [Full Text] [Related]
20. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
[Next]
